Search Results - "Kute, Timothy"

Refine Results
  1. 1

    Yin Yang 1 Plays an Essential Role in Breast Cancer and Negatively Regulates p27 by Wan, Meimei, Huang, Weiwei, Kute, Timothy E, Miller, Lance D, Zhang, Qiang, Hatcher, Heather, Wang, Jingxuan, Stovall, Daniel B, Russell, Gregory B, Cao, Paul D, Deng, Zhiyong, Wang, Wei, Zhang, Qingyuan, Lei, Ming, Torti, Suzy V, Akman, Steven A, Sui, Guangchao

    Published in The American journal of pathology (01-05-2012)
    “…Yin Yang 1 (YY1) is highly expressed in various types of cancers and regulates tumorigenesis through multiple pathways. In the present study, we evaluated YY1…”
    Get full text
    Journal Article
  2. 2

    Yin Yang 1 promotes mTORC2-mediated AKT phosphorylation by Zhang, Qiang, Wan, Meimei, Shi, Jinming, Horita, David A, Miller, Lance D, Kute, Timothy E, Kridel, Steven J, Kulik, George, Sui, Guangchao

    Published in Journal of molecular cell biology (01-06-2016)
    “…Yin Yang 1 (YY1) regulates both gene expression and protein modifications, and has shown a proliferative role in cancers. In this study, we demonstrate that…”
    Get full text
    Journal Article
  3. 3

    Multidrug resistance protein 1 (MRP1, ABCC1) mediates resistance to mitoxantrone via glutathione-dependent drug efflux by Morrow, Charles S, Peklak-Scott, Christina, Bishwokarma, Bimjhana, Kute, Timothy E, Smitherman, Pamela K, Townsend, Alan J

    Published in Molecular pharmacology (01-04-2006)
    “…Based upon several previous reports, no consistent relationship between multidrug resistance protein 1 (MRP1, ABCC1) expression and cellular sensitivity to…”
    Get more information
    Journal Article
  4. 4

    Breast tumor cells isolated from in vitro resistance to trastuzumab remain sensitive to trastuzumab anti-tumor effects in vivo and to ADCC killing by Kute, Timothy E, Savage, Lori, Stehle, John R. Jr, Kim-Shapiro, Jung W, Blanks, Michael J, Wood, James, Vaughn, James P

    Published in Cancer Immunology, Immunotherapy (01-11-2009)
    “…An understanding of model systems of trastuzumab (Herceptin) resistance is of great importance since the humanized monoclonal antibody is now used as first…”
    Get full text
    Journal Article
  5. 5

    Inhibition of DNA Synthesis by a Platinum–Acridine Hybrid Agent Leads to Potent Cell Kill in Nonsmall Cell Lung Cancer by Smyre, Christopher L, Saluta, Gilda, Kute, Timothy E, Kucera, Gregory L, Bierbach, Ulrich

    Published in ACS medicinal chemistry letters (10-11-2011)
    “…The platinum–acridine anticancer agent [PtCl(en)(LH)](NO3)2 (1) [en = ethane-1,2-diamine, LH = N-(2-(acridin-9-ylamino)ethyl)-N-methylpropionimidamide,…”
    Get full text
    Journal Article
  6. 6

    Understanding key assay parameters that affect measurements of trastuzumab-mediated ADCC against Her2 positive breast cancer cells by Kute, Timothy, Stehle, Jr, John R., Ornelles, David, Walker, Natalie, Delbono, Osvaldo, Vaughn, James P.

    Published in Oncoimmunology (01-09-2012)
    “…Use of the antibody trastuzumab to kill HER2+ breast cancer cells is an attractive therapy because of its specificity and minimal adverse effects. However, a…”
    Get full text
    Journal Article
  7. 7

    SOSTDC1 differentially modulates Smad and beta-catenin activation and is down-regulated in breast cancer by Clausen, Kathryn A., Blish, Kimberly R., Birse, Charles E., Triplette, Matthew A., Kute, Timothy E., Russell, Gregory B., D’Agostino, Ralph B., Miller, Lance D., Torti, Frank M., Torti, Suzy V.

    Published in Breast cancer research and treatment (01-10-2011)
    “…Sclerostin domain containing 1 (SOSTDC1) protein regulates processes from development to cancer by modulating activity of bone morphogenetic protein (BMP) and…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Tachpyridine, a metal chelator, induces G2 cell-cycle arrest, activates checkpoint kinases, and sensitizes cells to ionizing radiation by Turner, JoLyn, Koumenis, Constantinos, Kute, Timothy E., Planalp, Roy P., Brechbiel, Martin W., Beardsley, Dillon, Cody, Brooke, Brown, Kevin D., Torti, Frank M., Torti, Suzy V.

    Published in Blood (01-11-2005)
    “…Iron is critical for cell growth and proliferation. Iron chelators are being explored for a number of clinical applications, including the treatment of…”
    Get full text
    Journal Article
  10. 10

    erbB-2, p53, and Efficacy of Adjuvant Therapy in Lymph Node-Positive Breast Cancer by Thor, Ann D., Berry, Donald A., Budman, Daniel R., Muss, Hyman B., Kute, Timothy, Henderson, I. Craig, Barcos, Maurice, Cirrincione, Constance, Edgerton, Susan, Allred, Craig, Norton, Larry, Liu, Edison T.

    “…Background: We have previously reported that high expression of the erbB-2 gene (also known as HER-2/neu and ERBB2) in breast cancer is associated with patient…”
    Get full text
    Journal Article
  11. 11

    Development of Herceptin resistance in breast cancer cells by Kute, Timothy, Lack, Christopher M., Willingham, Mark, Bishwokama, Bimjhana, Williams, Holly, Barrett, Kathy, Mitchell, Tanita, Vaughn, James P.

    Published in Cytometry. Part A (01-02-2004)
    “…Background Herceptin, a humanized antibody to HER‐2, is now utilized in the clinic for metastatic breast cancer treatment. The response rate for HER‐2+…”
    Get full text
    Journal Article
  12. 12

    5-Oxo-ETE analogs and the proliferation of cancer cells by O'Flaherty, Joseph T., Rogers, LeAnn C., Paumi, Christian M., Hantgan, Roy R., Thomas, Lance R., Clay, Carl E., High, Kevin, Chen, Yong Q., Willingham, Mark C., Smitherman, Pamela K., Kute, Timothy E., Rao, Anuradha, Cramer, Scott D., Morrow, Charles S.

    Published in Biochimica et biophysica acta (01-10-2005)
    “…MDA-MB-231, MCF7, and SKOV3 cancer cells, but not HEK-293 cells, expressed mRNA for the leukocyte G protein-coupled 5-oxo-eicosatetraenoate (ETE) OXE receptor…”
    Get full text
    Journal Article
  13. 13

    Genistein and vitamin D synergistically inhibit human prostatic epithelial cell growth by Rao, Anuradha, Woodruff, Ralph D, Wade, Wendy N, Kute, Timothy E, Cramer, Scott D

    Published in The Journal of nutrition (01-10-2002)
    “…We performed studies to test synergism between the growth inhibitory effects of genistein and vitamin D compounds on prostatic epithelial cells. Isobolographic…”
    Get more information
    Journal Article
  14. 14

    Measurement of PTEN expression using tissue microarrays to determine a race-specific prognostic marker in breast cancer by Winter, Jerald Luke, Stackhouse, Bodiford L, Russell, Gregory B, Kute, Timothy E

    “…African American women with breast cancer have worse prognoses than non-African Americans and might benefit with a race-specific prognostic marker such as PTEN…”
    Get full text
    Journal Article
  15. 15

    Expression of Microtubule-Associated Protein 2 in Benign and Malignant Melanocytes : Implications for Differentiation and Progression of Cutaneous Melanoma by Fang, Dong, Hallman, James, Sangha, Namrata, Kute, Timothy E, Hammarback, James A, White, Wain L, Setaluri, Vijayasaradhi

    Published in The American journal of pathology (01-06-2001)
    “…Cutaneous melanocytic neoplasms are known to acquire variable characteristics of neural crest differentiation. Melanocytic nevus cells in the dermis and…”
    Get full text
    Journal Article
  16. 16

    Intrabody-based strategies for inhibition of vascular endothelial growth factor receptor-2: effects on apoptosis, cell growth, and angiogenesis by Wheeler, Yurong Yang, Kute, Timothy E, Willingham, Mark C, Chen, Si-Yi, Sane, David C

    Published in The FASEB journal (01-09-2003)
    “…VEGF, an endothelial-specific mitogen, is an important tumor angiogenesis growth factor. The major receptor for VEGF on endothelial cells is KDR. We…”
    Get full text
    Journal Article
  17. 17

    DNA strand breaks and cell cycle perturbation in Herceptin treated breast cancer cell lines by MAYFIELD, Scott, VAUGHN, James P, KUTE, Timothy E

    Published in Breast cancer research and treatment (01-11-2001)
    “…Herceptin is a humanized antibody that binds to the product of the HER-2 oncogene. Clinical studies have indicated that treatment with Herceptin may slow…”
    Get full text
    Journal Article
  18. 18

    Influence of J series prostaglandins on apoptosis and tumorigenesis of breast cancer cells by Clay, Carl E., Namen, Andrew M., Atsumi, Gen-ichi, Willingham, Mark C., High, Kevin P., Kute, Timothy E., Trimboli, Anthony J., Fonteh, Alfred N., Dawson, Paul A., Chilton, Floyd H.

    Published in Carcinogenesis (New York) (01-10-1999)
    “…This study was undertaken to investigate the influence of the peroxisome proliferator-activated receptor γ (PPARγ) agonists on the proliferation, apoptosis and…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Cathepsin D as a prognostic indicator for node-negative breast cancer patients using both immunoassays and enzymatic assays by KUTE T. E, ZHI-MING SHAO, SUGG, N. K, LONG, R. T, RUSSELL, G. B, CASE, L. D

    Published in Cancer research (Chicago, Ill.) (01-10-1992)
    “…This is a retrospective study on 162 node-negative patients, with both biochemical and clinical factors being measured for determination of prognostic markers…”
    Get full text
    Journal Article